The Nonmydriatic Fundus Camera in Diabetic Retinopathy Screening: A Cost-Effective Study with Evaluation for Future Large-Scale Application

Table 3

Economic resources related to the investigated procedures.

Screening programme pathway
Phase I	164,026.11
Phase II	121,230.90
Phase III	160,924.94
Phase IV (treatment)	1,154,724.70
Investment in equipment	72,000.00
Blindness	35,843.46
Total	1,708,750,11
“Do nothing” strategy
Blindness	134,424.00
Treatment	1,845,869.43
Total	1,980,293.43
Economic savings	−271,543.32
	−13.71%